KTX-1001 / K36 Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
KTX-1001 / K36 Therap
KTX-MMSET-001, NCT05651932: A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Recruiting
1
60
Europe, Canada, US
KTX-1001
K36 Therapeutics, Inc.
Multiple Myeloma, Myeloma, Myeloma Multiple
12/24
10/25

Download Options